Chapter 96: Experimental Revelations

Chapter 96: Experimental Revelations

The secure research laboratory deep within Sterling Dynamics hummed with urgent activity. Dr. Elena Chen stared at genetic test results with growing alarm, her scientific composure shaken by the implications.

"These pharmaceutical compounds target specific supernatural markers," she explained to Luna Stone, displaying complex molecular structures. "Someone deliberately engineered drugs to affect werewolf genetics."

Dante Romano studied the laboratory data with predatory focus. "Multiple pack territories report unusual health patterns," he shared, connecting scattered incidents. "Symptoms matching these compounds."

"BlackCross Pharmaceuticals leads distribution networks," Sarah Williams reported, tracking supply chains. "Their research facilities show unusual security protocols."

Luna analyzed the molecular data with strategic precision. "These drugs modify supernatural characteristics," she noted, understanding deeper implications. "Attempting controlled genetic manipulation."

"Pack blood samples show widespread exposure," Dr. Chen continued, bringing up test results. "Low-level compounds already present in multiple populations."

Dante received urgent communications from affected territories. "Northern packs report decreased strength levels," he growled, protective instincts rising. "Reduced healing capabilities."

"Distribution patterns suggest careful targeting," Sarah observed, mapping affected areas. "Corporate pharmaceutical channels reaching specific communities."

Dr. Chen highlighted critical genetic markers. "Your unique DNA provides natural resistance," she told Luna. "Enhanced supernatural adaptation preventing chemical manipulation."

"BlackCross maintains extensive supernatural research programs," Sarah discovered, penetrating corporate firewalls. "Hidden facilities conducting genetic experiments."

Luna accessed secure corporate databases. "Their pharmaceutical division expanded rapidly," she noted, tracking business patterns. "Focusing on territories with supernatural populations."

"These compounds alter fundamental pack characteristics," Dr. Chen explained, analyzing molecular structures. "Targeting specific genetic sequences."

Dante coordinated with affected pack leaders. "Southern territories show similar symptoms," he reported, gathering intelligence. "Strength reduction following pharmaceutical presence."

"BlackCross executives hold connections with supernatural research groups," Sarah uncovered, tracking corporate relationships. "Coordinated experimental programs."

Luna recognized broader strategic implications. "They attempt systematic control," she stated, understanding the threat. "Pharmaceutical manipulation of supernatural communities."

Dr. Chen brought up detailed genetic comparisons. "Your bloodline carries natural countermeasures," she told Luna. "Inherited resistance protecting against manipulation."

"Pack healing abilities show decreased effectiveness," Dante shared, receiving medical reports. "Traditional remedies proving inadequate."

Sarah traced pharmaceutical distribution networks. "BlackCross products reach supernatural populations through multiple channels," she reported. "Legal medications carrying hidden compounds."

"Their research facilities maintain supernatural containment measures," Luna observed, analyzing security protocols. "Prepared for genetic experimentation."

Dr. Chen studied molecular interaction patterns. "These compounds target specific supernatural traits," she explained. "Designed for controlled modification."

Dante received additional health reports. "Western packs show increasing symptoms," he noted, concern evident. "Supernatural capabilities declining steadily."

"BlackCross research budgets focus on genetic manipulation," Sarah discovered, tracking financial records. "Massive investment in supernatural studies."

Luna accessed classified research data. "Their experiments follow systematic progression," she observed, recognizing strategic patterns. "Building toward complete control."

Dr. Chen analyzed blood sample variations. "Affected populations show consistent changes," she reported. "Supernatural characteristics becoming suppressed."

"Pack leaders demand immediate action," Dante shared, coordinating responses. "Traditional strengths facing pharmaceutical threat."

Sarah uncovered experimental protocols. "BlackCross testing programs expand rapidly," she noted, tracking facility growth. "Increasing supernatural research capacity."

"Their corporate strategy targets vulnerable communities," Luna stated, understanding tactical approach. "Using medical distribution networks."

Dr. Chen highlighted resistance factors. "Your genetic structure provides crucial insight," she told Luna. "Natural protection suggesting possible countermeasures."

"Multiple territories require immediate assistance," Dante reported, organizing medical support. "Pack health declining under chemical influence."

Sarah traced research facility locations. "BlackCross maintains hidden supernatural laboratories," she discovered. "Conducting extensive genetic testing."

Luna analyzed corporate security measures. "Their facilities expect supernatural intervention," she noted, studying defensive protocols. "Prepared for pack resistance."

Dr. Chen developed preliminary treatments. "Your blood samples show promising applications," she reported. "Natural resistance offering potential protection."

"Pack strength requires immediate restoration," Dante stated, protective instincts demanding action. "Supernatural communities facing systematic threat."

Sarah mapped affected populations. "BlackCross influence spreads through medical networks," she observed. "Reaching isolated supernatural groups."

"Their research combines corporate resources with supernatural knowledge," Luna noted, understanding dangerous implications. "Creating unprecedented threat."

Dr. Chen studied protective possibilities. "Your genetic resistance suggests defensive options," she told Luna. "Natural adaptation providing crucial answers."

Sterling Dynamics' research facilities mobilized against this pharmaceutical threat. Corporate resources combined with supernatural insight, developing essential countermeasures.

Luna's unique genetic structure offered critical advantages. Her natural resistance provided hope for affected supernatural communities, suggesting possible protection.

Dante coordinated immediate pack responses. Traditional supernatural strength faced unprecedented challenges, requiring modern scientific solutions.

BlackCross Pharmaceuticals represented systematic manipulation. Corporate power targeting supernatural communities through sophisticated chemical means.

The experimental revelations demanded decisive action. Luna and Dante's partnership faced crucial challenges protecting supernatural populations from pharmaceutical control.